Amiloidózis: vizsgálatok itt: Mexikó

4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  Where

  Mexico City

  Életkor

  18 év to 90 év

  People

  1200 worldwide

  Run by

  Intellia Therapeutics

  See details and how to joinNCT06128629 · EU 2023-507220-23-00
• 3. fázisTaking people
  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Where

  Tlalpan

  Életkor

  18 év to 85 év

  People

  1750 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07052903 · EU 2024-519917-72-00
• 3. fázisTaking people
  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  Where

  Guadalajara, Tlalpan

  Életkor

  18 év to 85 év

  People

  125 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07223203 · EU 2025-522544-40-00
• 3. fázisTaking people
  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  Where

  Tlalpan

  Életkor

  18 év to 75 év

  People

  587 worldwide

  Run by

  Eidos Therapeutics, a BridgeBio company

  See details and how to joinNCT06563895 · EU 2024-513547-82-00